Pharmalittle: We’re reading about Medicare and obesity drugs, GSK asthma inhalers, and more
The Congressional Budget Office forecast that Medicare will likely choose the obesity drug semaglutide for price negotiation “within the next few years.”
The Congressional Budget Office forecast that Medicare will likely choose the obesity drug semaglutide for price negotiation “within the next few years.”
Ascension disclosed Wednesday that it has detected “unusual activity” on some of its technology networks that it believes “is due to a cybersecurity event.” |…
Patients say the device allows them to reduce the number of hospital visits involved in cancer care.
As many conservatives hail the fall of Roe for saving unborn lives, high-risk pregnancy becomes even more perilous.
The law prohibits telehealth appointments for abortion, but some groups are already using out-of-state physicians to prescribe the necessary medications.
This report discusses three cases of extrapulmonary Myocobacterium abscessus infections associated with stem cell treatment clinics in Mexico.
This week on “The Readout LOUD” podcast: What happens when a common virus jumps from birds to cows? And should we be concerned?
The monthly Cancer Prevention Works newsletter provides the latest information about activities and accomplishments in CDC’s Division of Cancer Prevention and Control.
The U.S. drug regulator has pushed back its decision on Moderna’s respiratory syncytial virus (RSV) vaccine due to “administrative constraints” and will complete the review…
More and more studies show that alcohol isn’t healthy after all. Dietary guidelines are up for revision in 2025, and already, there’s debate over research…
prostate cancer, advanced prostate cancer, androgen deprivation therapy (ADT), Relugolix, Dosing of Relugolix, gonadotropin-releasing hormone (GnRH) receptor antagonist, HERO study, abiraterone acetate, apalutamide, metastatic castration-sensitive…